Background/objectives: The association between systemic inflammation and myosteatosis upon diagnosis of gastric cancer (GC) and whether these factors could predict survival outcomes is not clear. Our aim was to explore the association between systemic inflammation and myosteatosis upon diagnosis of GC, specially whether the co-occurrence of these factors could predict survival outcomes.
Subjects/methods: Computed tomography (CT) was performed at the level of the third lumbar vertebra for body composition analysis in 280 patients with GC.